← Open Payments lookup

JENIFER BRANSON: Open Payments

NPI 1235312299 · MELISSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$404 in 22 payments from 13 companies in 2025. Trend: 2023 $572 · 2024 $542 · 2025 $404

Food & beverage: $404
CompanyPaymentsAmount
GlaxoSmithKline, LLC.2$54
Dexcom, Inc.3$54
Otsuka America Pharmaceutical, Inc.2$47
Antares Pharma, Inc.3$47
Phathom Pharmaceuticals, Inc.2$35
Lilly USA, LLC2$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
ABBVIE INC.1$22
Abbott Laboratories1$20
Novo Nordisk Inc1$20

Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, REXULTI, XYOSTED, VOQUEZNA, MOUNJARO, XIFAXAN, QULIPTA.

Industry payments across TX — which companies pay providers there.